GSDMB
Gasdermin B: A key mediator of pyroptosis and inflammatory disease susceptibility
Gene Information Card
| Symbol | GSDMB |
|---|---|
| Full Name | Gasdermin B |
| Gene Type | Protein coding |
| Chromosomal Location | 17q21.1 |
| NCBI Gene ID | 55876 ncbi.nlm.nih.gov/gene/55876 |
| Ensembl ID | ENSG00000073605 |
| UniProt ID | Q8TAX9 |
| OMIM ID | 611221 |
| HGNC ID | 24856 |
| Aliases | GSDML, PP4052, PRO2521 |
Description
GSDMB (gasdermin B) is a member of the gasdermin protein family, which plays a critical role in pyroptosis, a form of inflammatory programmed cell death. The gene is located on chromosome 17q21.1 within a region associated with susceptibility to asthma, inflammatory bowel disease, and other inflammatory disorders. GSDMB is expressed in epithelial cells and immune cells, and its protein product forms pores in the plasma membrane upon cleavage by caspases or granzyme B, leading to cell lysis and release of pro-inflammatory cytokines. Alternative splicing generates multiple isoforms with distinct functions.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Asthma | GSDMB overexpression in airway epithelium enhances pyroptosis and IL-1β release, contributing to airway inflammation and hyperresponsiveness. | GWAS and functional studies (PMID: 28593948, 30833798) |
| Inflammatory Bowel Disease (IBD) | Risk variants in the 17q21.1 locus increase GSDMB expression in intestinal epithelial cells, promoting pyroptosis and disrupting barrier integrity. | GWAS and eQTL analyses (PMID: 28067908, 31570887) |
| Cancer (e.g., breast, gastric) | GSDMB expression is altered in various cancers; it can promote or suppress tumor growth depending on context. In some cancers, GSDMB-mediated pyroptosis may enhance anti-tumor immunity. | Expression studies and functional assays (PMID: 27498864, 31729385) |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Esophagus | 12.5 | Medium |
| Lung | 8.3 | Medium |
| Small intestine | 7.1 | Medium |
| Colon | 6.8 | Medium |
| Stomach | 5.9 | Low |
| Skin | 4.2 | Low |
| Spleen | 3.1 | Low |
| Liver | 1.5 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| A549 (lung carcinoma) | 15.2 | High expression |
| Caco-2 (colorectal adenocarcinoma) | 9.8 | Medium expression |
| HEK 293 (embryonic kidney) | 4.5 | Low expression |
| HeLa (cervical carcinoma) | 3.1 | Low expression |
| K562 (leukemia) | 1.2 | Not detected |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| rs2305480 (G>A) | SNP (intronic) | 0.45 (East Asian) | Associated with increased GSDMB expression and asthma risk |
| rs11078928 (C>T) | SNP (intronic) | 0.30 (European) | Associated with reduced GSDMB expression and protection from asthma |
| p.Arg47His | Missense | Rare | Alters pore formation activity; functional impact unclear |
Mutation functional classification
Loss of Function (LOF)
No well-characterized loss-of-function mutations reported in GSDMB; however, some rare missense variants may reduce pore-forming activity.
Gain of Function (GOF)
Increased expression due to risk SNPs (e.g., rs2305480) is considered a gain-of-function at the transcript level, enhancing pyroptosis.
Dominant Negative (DN)
Not described for GSDMB.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Pyroptosis (Reactome: R-HSA-5620971)
• Interleukin-1 family signaling (Reactome: R-HSA-446652)
• Innate immune system (Reactome: R-HSA-168249)
Protein Summary
Gasdermin B (GSDMB) is a 411-amino acid protein (isoform 1) that contains an N-terminal pore-forming domain and a C-terminal regulatory domain. Upon proteolytic cleavage by caspase-1, caspase-3, or granzyme B, the N-terminal domain oligomerizes and inserts into the plasma membrane, forming pores that disrupt ion homeostasis and induce pyroptosis. GSDMB is highly expressed in epithelial tissues of the gastrointestinal and respiratory tracts, where it modulates inflammatory responses. Alternative splicing produces multiple isoforms with varying activity and tissue distribution.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GSDMB Knockout HEK293 Cell Line | EDJ-KQ13691 | Human | 55876 | Details Get a Quote |
| GSDMB Knockout A-549 Cell Line | EDJ-KQ43390 | Human | 55876 | Details Get a Quote |
| GSDMB Knockout HCT 116 Cell Line | EDJ-KQ43391 | Human | 55876 | Details Get a Quote |
| GSDMB Knockout HeLa Cell Line | EDJ-KQ43392 | Human | 55876 | Details Get a Quote |
| GSDMB Knockout HTR-8/SVneo Cell Line | EDJ-KZ272 | Human | 55876 | Details Get a Quote |
Displaying Records 1 To 5 Of 5 Records